What is the minimum ticket size and moratorium for Greenfield Hospital Project Finance?

CreditCares structures greenfield and brownfield hospital project loans starting from ₹10 Crore up to ₹500 Crore, featuring a principal moratorium of 24 to 36 months post-Commercial Operations Date (CoD) and door-to-door tenures of 12 to 15 years.

How does CreditCares structure USFDA and WHO-GMP Pharma API manufacturing loans?

We syndicate term debt and working capital consortiums (CC/OD/PCFC/LC) across 80+ PSU and Private Banks for API bulk drug plants, sterile injectable lines, and Zero Liquid Discharge (ZLD) effluent systems at indicative rates of 8.40% to 8.95% p.a., aligned with PLI and state industrial capital subsidies.

EX-BANKER SYNDICATION DESK • INSTITUTIONAL ADVISORY

Healthcare & Pharma Corporate Project Finance (₹10 Cr – ₹500 Cr)

Direct institutional debt syndication across 80+ PSU Banks, Private Banks, and DFIs. We structure greenfield hospital capex, brownfield bed expansion, and USFDA/WHO-GMP bulk drug API facilities with custom principal moratoriums and lowest EBLR/MCLR spreads.

8.35% p.a.*Indicative Consortium Rate

24–36 MosPost-CoD Principal Moratorium

₹3,500+ CrCorporate Debt Syndicated

Instant Mandate Term-Sheet Estimator

Check DSCR bankability & indicative consortium pricing

Project Vertical *

Required Debt Quantum (₹ Crore) *

Promoter / Corporate Entity Name & City *

Indicative ROI Band 8.35% – 8.85%

Max Moratorium 36 Months

Max Door-to-Door 15 Years

Engineered for Capital-Intensive Lifesciences Mandates

Retail loan brokers fail on ₹25Cr+ healthcare and pharma projects because standard banking templates ignore gestation cycles. Our Ex-Banker credit cell prepares end-to-end TEV reports, DPRs, and CMA models tailored to clinical and regulatory cash flows.

1. Healthcare & Hospital Project Finance

Greenfield & Brownfield Capex: ₹10 Cr to ₹500 Cr term debt for 100 to 1,000+ bed multispecialty, oncology, and mother-and-child hospitals.
Gestation-Aligned Moratorium: 24 to 36 months principal moratorium allowing ICU/IPD occupancy and insurance empanelment (TPA/CGHS) to stabilize before EMI step-up.
Medical Equipment Leasing & Capex: Up to 85% LTV funding for 3T MRI, Cath Labs, PET-CT, Linear Accelerators (LINAC), and modular OTs with OEM buyback structuring.
Existing High-Cost Debt Takeover: Refinancing NBFC debt into PSU/Private Bank consortiums with 100–175 bps interest rate reduction.

2. Pharma, Bulk Drug (API) & Biotech Advisory

Regulatory Plant Capex: Project finance for USFDA, EU-GMP, UK-MHRA, and WHO-GMP compliant sterile injectables, OSD, and fermentation-based API facilities.
Environmental & Utility Funding: Dedicated term debt trenches for Zero Liquid Discharge (ZLD) effluent plants, HVAC cleanrooms, and captive solar/cogeneration power.
Working Capital & Export Consortiums: Multi-bank CC/OD harmonization, Pre- and Post-Shipment Credit in Foreign Currency (PCFC/EBR), and zero-margin Letter of Credit (LC) limits.
Industrial Cluster Expertise: Active syndication across Hyderabad Genome Valley, Ahmedabad/Sanand GIDC, Visakhapatnam Pharma City, Baddi, and Sikkim/Kolkata corridors.

Credit Parameter	Greenfield / Brownfield Hospitals	USFDA / WHO-GMP Pharma & API	Working Capital / Debt Takeover
Mandate Ticket Size	₹15 Crore – ₹500 Crore	₹10 Crore – ₹350 Crore	₹10 Crore – ₹250 Crore
Indicative Interest Rate	8.35% – 8.90% p.a. (EBLR/MCLR)	8.40% – 8.95% p.a.	8.25% – 8.80% p.a. (PCFC from SOFR+120bps)
Benchmark DSCR & DER	Min. Avg DSCR 1.45x \| DER up to 2.25:1	Min. Avg DSCR 1.55x \| DER up to 2.00:1	Current Ratio ≥ 1.33x \| Drawing Power Linked
Sanction Turnaround	21 – 30 Working Days (Consortium)	18 – 25 Working Days	14 – 21 Working Days